Why the study?
To assess the utility of the MAFLD definition's approach classifying patients into diabetic, overweight/obese, and lean subgroups to define clinically homogenous groups.
Does the MAFLD subgroup classification predict all-cause and cardiovascular mortality in adults?
Population
7562 non-pregnant adults aged between 20 and 74 years from NHANES III
Comparison
No MAFLD vs MAFLD-overweight/obese vs MAFLD-diabetes vs MAFLD-lean
Design
Cohort analysis of NHANES III survey data
Follow-up
26.8 years (IQR 22.7–28.8 years)
Authors
Loading...
Merits caution applying the steatotic liver disease definition; leaves open optimal criteria for metabolic fatty liver disease.
Does the MAFLD subgroup classification predict all-cause and cardiovascular mortality in adults?
The MAFLD definition effectively identifies three homogenous patient groups with distinct risks for all-cause and cardiovascular mortality, with the MAFLD-diabetes group having the highest risk.
Pan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: